Medication info
Telmisartan/Amlodipine Tablets 40/5 mg

Telmisartan/Amlodipine Tablets 40/5 mg

Prescription medicationOral
Ingredient · strength
Telmisartan›40mg / 1 tabletAmlodipine Besylate›6.935mg / 1 tablet
Manufacturer / importer
Huvis Pharmaceutical Co., Ltd.
Appearance
White and light blue, double-convex oval tablets
Packaging
30 tablets (10 tablets/PTP x 3), 30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201700619 · Approved 2017.02.06 · Insurance code 628800960

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended to adjust the dose using the individual components (telmisartan or amlodipine). However, if blood pressure is not controlled with an individual component as described below, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. For patients taking telmisartan and amlodipine concomitantly, they may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience (limited to this medicine 40/5 mg). ○ Patients with renal impairment: No dose adjustment is necessary for patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a low dose and gradually increase the dose. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine dosage regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring cautious administration’). In older adults aged 75 years or older, clearance of amlodipine is reduced; therefore, start treatment at a low dose and increase the dose gradually.
Child dose
The safety and efficacy of this drug have not been established in pediatric patients 18 years of age or younger; its use is not recommended.

Ingredients

Manufacturer
Huvis Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

Used for patients with essential hypertension where blood pressure control is inadequate with monotherapy with telmisartan or amlodipine, effectively lowering blood pressure to improve hypertension.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended to adjust the dose using the individual components (telmisartan or amlodipine). However, if blood pressure is not controlled with an individual component as described below, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. For patients taking telmisartan and amlodipine concomitantly, they may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience (limited to this medicine 40/5 mg). ○ Patients with renal impairment: No dose adjustment is necessary for patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a low dose and gradually increase the dose. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine dosage regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring cautious administration’). In older adults aged 75 years or older, clearance of amlodipine is reduced; therefore, start treatment at a low dose and increase the dose gradually.

Child dose

The safety and efficacy of this drug have not been established in pediatric patients 18 years of age or younger; its use is not recommended.

Precautions

This medication can pose serious risks to the fetus during pregnancy, especially in the second and third trimesters, and should not be taken by women who are pregnant or may become pregnant. This medication should not be administered to patients with specific conditions, such as severe liver impairment, severe hypotension, cardiogenic shock, or patients with unstable blood flow after acute myocardial infarction. Use with caution in specific patient groups, such as those with primary aldosteronism, aortic or mitral stenosis, liver impairment, gastrointestinal diseases, renovascular hypertension, dialysis patients, and the elderly, as dosage adjustments or careful monitoring may be required. The most common side effects of this medication are dizziness and peripheral edema, and rare occurrences of fainting or serious allergic reactions may occur; any unusual symptoms should be reported to a healthcare provider immediately. The use of this medication during pregnancy can be harmful to the fetus, therefore, if pregnancy is confirmed, discontinue use immediately and seek alternative treatment; breastfeeding women are also advised not to take this medication. This medication can interact with other drugs, thus, when taken with specific medications such as digoxin, lithium, warfarin, non-steroidal anti-inflammatory drugs, etc., it is essential to inform the healthcare provider, and regular monitoring is necessary. Blood pressure may drop too low while taking this medication; if symptoms of hypotension occur, lie down immediately and seek assistance from a healthcare provider if necessary. In cases of overdose, severe hypotension, tachycardia, dizziness, and acute renal failure may occur; strictly adhere to the prescribed dosage and visit a medical institution immediately if an overdose is suspected. This medication should not be recommended for children as its safety and efficacy have not been sufficiently established, and for the elderly, careful dosage adjustments are necessary. When storing this medication, keep it out of reach of children, and take it immediately after opening; avoid transferring to other containers. Drowsiness or dizziness may occur when driving or operating dangerous machinery while taking this medication, so caution is advised.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 100 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • sensory abnormality
  • sensory loss
  • taste disorder
  • tremor
  • extrapyramidal disorder
  • muscle rigidity
  • visual impairment
  • diplopia
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • cough
  • dyspnea
  • rhinitis
  • change in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver dysfunction
  • liver disorder
  • hepatitis
  • jaundice
  • increased liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • hair loss
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug rash
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • renal dysfunction
  • urinary disorders
  • polyuria
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • increased liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin
  • intestinal vascular edema

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a container that protects it from light. Additionally, it is important to maintain a storage temperature between 1°C and 30°C to preserve the medication's efficacy.

Appearance and packaging

Appearance

White and light blue, double-convex oval tablets

Package unit

30 tablets (10 tablets/PTP x 3), 30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.